Navigation Links
Chemo May Boost Survival After Lung Cancer Surgery

Therapy improves outcome for some patients with operable disease, review finds

WEDNESDAY, March 24 (HealthDay News) -- Chemotherapy improves survival for patients with operable non-small cell lung cancer, say researchers who reviewed nearly 50 studies.

The first meta-analysis of 34 studies involving almost 8,500 patients (and more than 3,300 deaths) showed that survival at five years was 64 percent for patients who had chemotherapy and surgery, and 60 percent for patients who had surgery alone.

The second meta-analysis of 13 studies with 2,660 patients (1,909 deaths) showed that survival at five years was 33 percent for patients who had surgery plus radiotherapy and chemotherapy, and 29 percent for patients who had surgery plus radiotherapy alone.

The report was released online March 23 in advance of publication in an upcoming print issue of The Lancet.

"In both meta-analyses we noted little variation in effect according to the type of chemotherapy, other trial characteristics, or patient subgroup," wrote the British and French researchers.

According to a team led by Sarah Burdett of the Medical Research Council Clinical Trials Unit, London, adding in chemotherapy boosted outcomes whether or not patients got the treatment alongside surgery alone, or surgery plus radiotherapy. They contend that, in patients deemed suitable, "platinum-based chemotherapy should be considered for patients at high risk of recurrence -- i.e., those with stage 1B, 2 or 3 disease."

The finding supports the use of chemotherapy in patients with non-small cell lung cancer who have also undergone tumor-removing surgery, Dr. Gregory P. Kalemkerian, of the University of Michigan, wrote in an accompanying commentary.

"Although the survival benefit seems small, worldwide adoption of adjuvant chemotherapy could save up to 10,000 lives every year," he said.

More information

The U.S. National Cancer Institute has more about non-small cell lung cancer.

-- Robert Preidt

SOURCE: The Lancet, news release, March 23, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
2. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
3. Researchers find new chemotherapy combination shows promise in endometrial cancer
4. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
5. Are New Chemo Treatments Cost-Effective?
6. Older Colon Cancer Patients Less Likely to Get Chemo
7. Study evaluates costs and benefits of new chemotherapy drugs
8. Scientists identify microRNA as possible cause of chemotherapy resistance
9. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
10. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
11. Patients with resectable esophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology: